CN108703282A - 一种野生苦瓜降糖饮料及其制备方法 - Google Patents
一种野生苦瓜降糖饮料及其制备方法 Download PDFInfo
- Publication number
- CN108703282A CN108703282A CN201810942507.7A CN201810942507A CN108703282A CN 108703282 A CN108703282 A CN 108703282A CN 201810942507 A CN201810942507 A CN 201810942507A CN 108703282 A CN108703282 A CN 108703282A
- Authority
- CN
- China
- Prior art keywords
- parts
- wild
- balsam pear
- sichuan
- china
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000013361 beverage Nutrition 0.000 title claims abstract description 40
- 235000009811 Momordica charantia Nutrition 0.000 title claims abstract description 33
- 235000008322 Trichosanthes cucumerina Nutrition 0.000 title claims abstract description 28
- 238000002360 preparation method Methods 0.000 title claims abstract description 11
- 244000078912 Trichosanthes cucumerina Species 0.000 title 1
- 244000018716 Impatiens biflora Species 0.000 claims abstract description 33
- 235000015912 Impatiens biflora Nutrition 0.000 claims abstract description 33
- 235000014443 Pyrus communis Nutrition 0.000 claims abstract description 33
- 244000302512 Momordica charantia Species 0.000 claims abstract description 32
- 241000205585 Aquilegia canadensis Species 0.000 claims abstract description 21
- 239000002994 raw material Substances 0.000 claims abstract description 21
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 claims abstract description 20
- 244000228451 Stevia rebaudiana Species 0.000 claims abstract description 16
- 238000002156 mixing Methods 0.000 claims description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 4
- 238000000746 purification Methods 0.000 claims description 2
- 239000008280 blood Substances 0.000 abstract description 17
- 210000004369 blood Anatomy 0.000 abstract description 17
- 230000000694 effects Effects 0.000 abstract description 13
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 6
- 230000003247 decreasing effect Effects 0.000 abstract description 5
- 230000000144 pharmacologic effect Effects 0.000 abstract description 3
- 238000010926 purge Methods 0.000 abstract description 3
- 230000002708 enhancing effect Effects 0.000 abstract description 2
- 231100000614 poison Toxicity 0.000 abstract description 2
- 239000002574 poison Substances 0.000 abstract description 2
- 231100000331 toxic Toxicity 0.000 abstract description 2
- 230000002588 toxic effect Effects 0.000 abstract description 2
- 239000008103 glucose Substances 0.000 description 28
- 230000002218 hypoglycaemic effect Effects 0.000 description 11
- 230000006870 function Effects 0.000 description 9
- 210000004185 liver Anatomy 0.000 description 9
- 201000001421 hyperglycemia Diseases 0.000 description 7
- 206010020772 Hypertension Diseases 0.000 description 6
- ZQSIJRDFPHDXIC-UHFFFAOYSA-N Daidzein Natural products C1=CC(O)=CC=C1C1=COC2=CC(O)=CC=C2C1=O ZQSIJRDFPHDXIC-UHFFFAOYSA-N 0.000 description 5
- 208000031226 Hyperlipidaemia Diseases 0.000 description 5
- 235000009812 Momordica cochinchinensis Nutrition 0.000 description 5
- 235000018365 Momordica dioica Nutrition 0.000 description 5
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 description 5
- 201000010099 disease Diseases 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- 230000004060 metabolic process Effects 0.000 description 5
- 239000000126 substance Substances 0.000 description 5
- 241000544066 Stevia Species 0.000 description 4
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
- 239000003814 drug Substances 0.000 description 4
- 235000013305 food Nutrition 0.000 description 4
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 4
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 3
- 244000247747 Coptis groenlandica Species 0.000 description 3
- 235000002991 Coptis groenlandica Nutrition 0.000 description 3
- GMTUGPYJRUMVTC-UHFFFAOYSA-N Daidzin Natural products OC(COc1ccc2C(=O)C(=COc2c1)c3ccc(O)cc3)C(O)C(O)C(O)C=O GMTUGPYJRUMVTC-UHFFFAOYSA-N 0.000 description 3
- KYQZWONCHDNPDP-UHFFFAOYSA-N Daidzoside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-UHFFFAOYSA-N 0.000 description 3
- 229930185803 charantin Natural products 0.000 description 3
- KYQZWONCHDNPDP-QNDFHXLGSA-N daidzein 7-O-beta-D-glucoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C2C(=O)C(C=3C=CC(O)=CC=3)=COC2=C1 KYQZWONCHDNPDP-QNDFHXLGSA-N 0.000 description 3
- 230000006378 damage Effects 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000000796 flavoring agent Substances 0.000 description 3
- 235000019634 flavors Nutrition 0.000 description 3
- 230000036039 immunity Effects 0.000 description 3
- 239000004615 ingredient Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 210000002784 stomach Anatomy 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 230000035922 thirst Effects 0.000 description 3
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 2
- 241000196324 Embryophyta Species 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- 208000008454 Hyperhidrosis Diseases 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 102000004877 Insulin Human genes 0.000 description 2
- 108090001061 Insulin Proteins 0.000 description 2
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 2
- 208000025865 Ulcer Diseases 0.000 description 2
- LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 2
- TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 2
- 230000001154 acute effect Effects 0.000 description 2
- 230000002929 anti-fatigue Effects 0.000 description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
- 235000019658 bitter taste Nutrition 0.000 description 2
- 150000001720 carbohydrates Chemical class 0.000 description 2
- 235000014633 carbohydrates Nutrition 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 229940074393 chlorogenic acid Drugs 0.000 description 2
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 2
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 2
- 235000001368 chlorogenic acid Nutrition 0.000 description 2
- 235000012000 cholesterol Nutrition 0.000 description 2
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 2
- 238000001784 detoxification Methods 0.000 description 2
- 208000002173 dizziness Diseases 0.000 description 2
- LXBIFEVIBLOUGU-JGWLITMVSA-N duvoglustat Chemical compound OC[C@H]1NC[C@H](O)[C@@H](O)[C@@H]1O LXBIFEVIBLOUGU-JGWLITMVSA-N 0.000 description 2
- 229930003935 flavonoid Natural products 0.000 description 2
- 235000017173 flavonoids Nutrition 0.000 description 2
- 150000002215 flavonoids Chemical class 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- VKOBVWXKNCXXDE-UHFFFAOYSA-N icosanoic acid Chemical compound CCCCCCCCCCCCCCCCCCCC(O)=O VKOBVWXKNCXXDE-UHFFFAOYSA-N 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 229940125396 insulin Drugs 0.000 description 2
- 210000000496 pancreas Anatomy 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000008439 repair process Effects 0.000 description 2
- 239000002689 soil Substances 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 231100000397 ulcer Toxicity 0.000 description 2
- 229940116269 uric acid Drugs 0.000 description 2
- 235000003563 vegetarian diet Nutrition 0.000 description 2
- CWVRJTMFETXNAD-BMNNCGMMSA-N (1s,3r,4s,5r)-3-[(e)-3-(3,4-dihydroxyphenyl)prop-2-enoyl]oxy-1,4,5-trihydroxycyclohexane-1-carboxylic acid Chemical compound O[C@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-BMNNCGMMSA-N 0.000 description 1
- VWEWSCDQMVNOJP-IPOZFMEPSA-N 7-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-3-[4-[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyphenyl]chromen-4-one Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(C=2C(C3=CC=C(O[C@H]4[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O4)O)C=C3OC=2)=O)C=C1 VWEWSCDQMVNOJP-IPOZFMEPSA-N 0.000 description 1
- 244000291564 Allium cepa Species 0.000 description 1
- 235000002732 Allium cepa var. cepa Nutrition 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 206010002368 Anger Diseases 0.000 description 1
- 206010002383 Angina Pectoris Diseases 0.000 description 1
- 206010003011 Appendicitis Diseases 0.000 description 1
- 206010003211 Arteriosclerosis coronary artery Diseases 0.000 description 1
- 208000004429 Bacillary Dysentery Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000345998 Calamus manan Species 0.000 description 1
- 235000002566 Capsicum Nutrition 0.000 description 1
- 240000008574 Capsicum frutescens Species 0.000 description 1
- 206010007247 Carbuncle Diseases 0.000 description 1
- 208000034710 Cerebral arteriovenous malformation Diseases 0.000 description 1
- 206010008570 Chloasma Diseases 0.000 description 1
- 241000272201 Columbiformes Species 0.000 description 1
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 1
- 241000721047 Danaus plexippus Species 0.000 description 1
- 206010012289 Dementia Diseases 0.000 description 1
- LXBIFEVIBLOUGU-UHFFFAOYSA-N Deoxymannojirimycin Natural products OCC1NCC(O)C(O)C1O LXBIFEVIBLOUGU-UHFFFAOYSA-N 0.000 description 1
- 108010082495 Dietary Plant Proteins Proteins 0.000 description 1
- 208000004232 Enteritis Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 206010017553 Furuncle Diseases 0.000 description 1
- 206010017915 Gastroenteritis shigella Diseases 0.000 description 1
- 206010019233 Headaches Diseases 0.000 description 1
- 206010019468 Hemiplegia Diseases 0.000 description 1
- STECJAGHUSJQJN-GAUPFVANSA-N Hyoscine Natural products C1([C@H](CO)C(=O)OC2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-GAUPFVANSA-N 0.000 description 1
- 208000002263 Intracranial Arteriovenous Malformations Diseases 0.000 description 1
- 206010067125 Liver injury Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010027146 Melanoderma Diseases 0.000 description 1
- 208000003351 Melanosis Diseases 0.000 description 1
- 201000009906 Meningitis Diseases 0.000 description 1
- 208000019695 Migraine disease Diseases 0.000 description 1
- STECJAGHUSJQJN-UHFFFAOYSA-N N-Methyl-scopolamin Natural products C1C(C2C3O2)N(C)C3CC1OC(=O)C(CO)C1=CC=CC=C1 STECJAGHUSJQJN-UHFFFAOYSA-N 0.000 description 1
- 206010028980 Neoplasm Diseases 0.000 description 1
- 244000061176 Nicotiana tabacum Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 244000046052 Phaseolus vulgaris Species 0.000 description 1
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 208000001431 Psychomotor Agitation Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 206010062237 Renal impairment Diseases 0.000 description 1
- 206010057190 Respiratory tract infections Diseases 0.000 description 1
- 206010038743 Restlessness Diseases 0.000 description 1
- 206010040047 Sepsis Diseases 0.000 description 1
- 241000191967 Staphylococcus aureus Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- QFVOYBUQQBFCRH-UHFFFAOYSA-N Steviol Natural products C1CC2(C3)CC(=C)C3(O)CCC2C2(C)C1C(C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-UHFFFAOYSA-N 0.000 description 1
- 241000194017 Streptococcus Species 0.000 description 1
- 244000269722 Thea sinensis Species 0.000 description 1
- 241000700605 Viruses Species 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- 206010000269 abscess Diseases 0.000 description 1
- 238000009825 accumulation Methods 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000001754 anti-pyretic effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 239000002221 antipyretic Substances 0.000 description 1
- 201000000034 arteriovenous malformations of the brain Diseases 0.000 description 1
- 230000005784 autoimmunity Effects 0.000 description 1
- 244000052616 bacterial pathogen Species 0.000 description 1
- 210000000227 basophil cell of anterior lobe of hypophysis Anatomy 0.000 description 1
- 230000003796 beauty Effects 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 1
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 1
- 230000023555 blood coagulation Effects 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 210000001124 body fluid Anatomy 0.000 description 1
- 239000010839 body fluid Substances 0.000 description 1
- 239000001390 capsicum minimum Substances 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 206010008118 cerebral infarction Diseases 0.000 description 1
- 208000026106 cerebrovascular disease Diseases 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000035603 choleresis Effects 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 230000003750 conditioning effect Effects 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 208000029078 coronary artery disease Diseases 0.000 description 1
- 230000008878 coupling Effects 0.000 description 1
- 238000010168 coupling process Methods 0.000 description 1
- 238000005859 coupling reaction Methods 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 235000007240 daidzein Nutrition 0.000 description 1
- -1 daizeol Chemical compound 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 208000013219 diaphoresis Diseases 0.000 description 1
- NFDFQCUYFHCNBW-SCGPFSFSSA-N dienestrol Chemical compound C=1C=C(O)C=CC=1\C(=C/C)\C(=C\C)\C1=CC=C(O)C=C1 NFDFQCUYFHCNBW-SCGPFSFSSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 230000035622 drinking Effects 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 230000002526 effect on cardiovascular system Effects 0.000 description 1
- 206010014599 encephalitis Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 150000008131 glucosides Chemical class 0.000 description 1
- 150000002338 glycosides Chemical class 0.000 description 1
- 231100000869 headache Toxicity 0.000 description 1
- 230000002949 hemolytic effect Effects 0.000 description 1
- 230000011132 hemopoiesis Effects 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 231100000234 hepatic damage Toxicity 0.000 description 1
- 208000006454 hepatitis Diseases 0.000 description 1
- 231100000283 hepatitis Toxicity 0.000 description 1
- 230000001631 hypertensive effect Effects 0.000 description 1
- 238000007654 immersion Methods 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 230000001939 inductive effect Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 229910052500 inorganic mineral Inorganic materials 0.000 description 1
- 230000003993 interaction Effects 0.000 description 1
- 230000031891 intestinal absorption Effects 0.000 description 1
- 230000000302 ischemic effect Effects 0.000 description 1
- KRZBCHWVBQOTNZ-DLDRDHNVSA-N isochlorogenic acid Natural products O[C@@H]1[C@H](C[C@@](O)(C[C@H]1OC(=O)C=Cc2ccc(O)c(O)c2)C(=O)O)OC(=O)C=Cc3ccc(O)c(O)c3 KRZBCHWVBQOTNZ-DLDRDHNVSA-N 0.000 description 1
- GOMNOOKGLZYEJT-UHFFFAOYSA-N isoflavone Chemical compound C=1OC2=CC=CC=C2C(=O)C=1C1=CC=CC=C1 GOMNOOKGLZYEJT-UHFFFAOYSA-N 0.000 description 1
- CJWQYWQDLBZGPD-UHFFFAOYSA-N isoflavone Natural products C1=C(OC)C(OC)=CC(OC)=C1C1=COC2=C(C=CC(C)(C)O3)C3=C(OC)C=C2C1=O CJWQYWQDLBZGPD-UHFFFAOYSA-N 0.000 description 1
- 235000008696 isoflavones Nutrition 0.000 description 1
- 210000005229 liver cell Anatomy 0.000 description 1
- 230000008818 liver damage Effects 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 208000004396 mastitis Diseases 0.000 description 1
- 230000004089 microcirculation Effects 0.000 description 1
- 206010027599 migraine Diseases 0.000 description 1
- 239000011707 mineral Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 208000010125 myocardial infarction Diseases 0.000 description 1
- 208000031225 myocardial ischemia Diseases 0.000 description 1
- 201000001119 neuropathy Diseases 0.000 description 1
- 230000007823 neuropathy Effects 0.000 description 1
- 235000018343 nutrient deficiency Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 230000004203 pancreatic function Effects 0.000 description 1
- 210000003681 parotid gland Anatomy 0.000 description 1
- 244000052769 pathogen Species 0.000 description 1
- 231100000915 pathological change Toxicity 0.000 description 1
- 230000036285 pathological change Effects 0.000 description 1
- 208000033808 peripheral neuropathy Diseases 0.000 description 1
- 231100000572 poisoning Toxicity 0.000 description 1
- 230000000607 poisoning effect Effects 0.000 description 1
- 231100000857 poor renal function Toxicity 0.000 description 1
- 244000062645 predators Species 0.000 description 1
- 238000010791 quenching Methods 0.000 description 1
- 235000012950 rattan cane Nutrition 0.000 description 1
- 230000008929 regeneration Effects 0.000 description 1
- 238000011069 regeneration method Methods 0.000 description 1
- 230000008327 renal blood flow Effects 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- STECJAGHUSJQJN-FWXGHANASA-N scopolamine Chemical compound C1([C@@H](CO)C(=O)O[C@H]2C[C@@H]3N([C@H](C2)[C@@H]2[C@H]3O2)C)=CC=CC=C1 STECJAGHUSJQJN-FWXGHANASA-N 0.000 description 1
- 229960002646 scopolamine Drugs 0.000 description 1
- 208000013223 septicemia Diseases 0.000 description 1
- QZAYGJVTTNCVMB-UHFFFAOYSA-N serotonin Chemical compound C1=C(O)C=C2C(CCN)=CNC2=C1 QZAYGJVTTNCVMB-UHFFFAOYSA-N 0.000 description 1
- 201000005113 shigellosis Diseases 0.000 description 1
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 1
- 229950005143 sitosterol Drugs 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000007958 sleep Effects 0.000 description 1
- 230000000391 smoking effect Effects 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- QFVOYBUQQBFCRH-VQSWZGCSSA-N steviol Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)CC1)C[C@H]2[C@@]2(C)[C@H]1[C@](C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-VQSWZGCSSA-N 0.000 description 1
- 229940032084 steviol Drugs 0.000 description 1
- 230000000638 stimulation Effects 0.000 description 1
- 230000035882 stress Effects 0.000 description 1
- 230000035900 sweating Effects 0.000 description 1
- 230000002195 synergetic effect Effects 0.000 description 1
- 206010044008 tonsillitis Diseases 0.000 description 1
- 239000003053 toxin Substances 0.000 description 1
- 231100000765 toxin Toxicity 0.000 description 1
- 230000002485 urinary effect Effects 0.000 description 1
- 230000002792 vascular Effects 0.000 description 1
- 208000019553 vascular disease Diseases 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000020097 white wine Nutrition 0.000 description 1
- 235000014101 wine Nutrition 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L2/00—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation
- A23L2/02—Non-alcoholic beverages; Dry compositions or concentrates therefor; Their preparation containing fruit or vegetable juices
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/28—Asteraceae or Compositae (Aster or Sunflower family), e.g. chamomile, feverfew, yarrow or echinacea
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/35—Caprifoliaceae (Honeysuckle family)
- A61K36/355—Lonicera (honeysuckle)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/42—Cucurbitaceae (Cucumber family)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/71—Ranunculaceae (Buttercup family), e.g. larkspur, hepatica, hydrastis, columbine or goldenseal
- A61K36/718—Coptis (goldthread)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Abstract
本发明提出一种野生苦瓜降糖饮料及其制备方法，该饮料包括如下重量份的原料：野生苦瓜100‑160份、川黄连30‑50份、金银花60‑88份和甜菊叶10‑15份。本发明使用野生苦瓜和川黄连，它们相互作用，各自药性增强，降血糖效果更佳，而野生苦瓜、川黄连、金银花和甜菊叶按上述重量份结合，不仅提升饮料整体的口感，还使得野生苦瓜、川黄连及金银花的整体降血糖效果得到提升。除此之外，还有清热解毒，消炎，保肝明目，清除血液中的毒素，调节体内的酸碱度的作用。本发明无毒副作用。
Description
技术领域
本发明涉及一种降糖饮料，尤其是一种野生苦瓜降糖饮料，还涉及其制备方法，属于食品领域。
背景技术
高血糖的危害短时间、一次性的高血糖对人体无严重损害。比如在应激状态 下或情绪激动、高度紧张时，可出现短暂的高血糖；一次进食大量的糖类，也可 出现短暂高血糖；
随后，血糖水平逐渐恢复正常。然而长期的高血糖会使全身各个组织器官发 生病变，导致急慢性并发症的发生。如胰腺功能衰竭、失水、电解质紊乱、营养 缺乏、抵抗力下降、肾功能受损、神经病变、眼底病变等。
虽然目前降血糖的食品或药物较多，然而，疗效并不佳，也存在用料、配伍不正确、不完善的问题，例如，现有技术也有采用普通苦瓜或者黄连作为成分之一，然而，两者作用并不明显，降血糖效果不佳。
发明内容
为了解决上述技术问题，一种野生苦瓜降糖饮料及其制备方法，本发明通过如下技术方案予以实现：
一种野生苦瓜降糖饮料，其特征在于：包括如下重量份的原料：野生苦瓜100-160份、川黄连30-50份、金银花60-88份和甜菊叶10-15份。
本发明涉及的野生苦瓜降糖饮料的制备方法，其特征在于：包括如下步骤：
步骤（1）准备原料
按如下重量份称取原料：野生苦瓜100-160份、川黄连30-50份、金银花60-88份和甜菊叶10-15份；
步骤（2）制备野生苦瓜降糖饮料
将步骤（1）的原料混合，加水覆盖，大火煮开后，小火煎煮25分钟左右或者采用常规低温萃取技术提纯，即得到野生苦瓜降糖饮料。
进一步地，野生苦瓜降糖饮料的用量为：每日3-5次，每次约200毫升。
本发明中：
野生苦瓜为君，其含类似胰岛素物质是普通苦瓜的数十倍，有明显的降血糖作用。性味甘苦寒凉，能清热、除烦、止渴，有清热解毒，消炎，降血糖的作用。
野生苦瓜中，针对血糖血压发挥作用的是两大物质：野生苦瓜甙和5-羟基色胺。野生苦瓜甙是β-谷甾醇-β-D-葡萄糖甙和5，25-豆甾二烯醇-3-葡萄糖甙的等分子混合物。野生苦瓜甙的功效，就是平稳降血糖，能改善胰岛素功能，修复β细胞；减轻和控制2型高血糖并发症；调节高血压、高血脂、高胆固醇，调节免疫力，促进新陈代谢。
川黄连为臣，性寒味苦，属治中焦湿热之要药，具有燥湿清热、泻火解毒的功能。降胃火、脾、胰腺、肝火。
野生苦瓜性味甘苦寒凉，降糖，川黄连-性寒味苦，消炎平肝，两者相互作用降血糖效果更佳。
金银花为佐，主要是清热解毒，主治温病发热、热毒血痢、痈疽疔毒等。现代研究证明，金银花含有绿原酸、木犀草素苷等药理活性成分，对溶血性链球菌、金黄葡萄球菌等多种致病菌及上呼吸道感染致病病毒等有较强的抑制力，另外还可增强免疫力、抗早孕、护肝、抗肿瘤、消炎、解热、止血（凝血）、抑制肠道吸收胆固醇等，其临床用途非常广泛，可与其它药物配伍用于治疗呼吸道感染、菌痢、急性泌尿系统感染、高血压等40余种病症。
金银花性寒，味甘，入肺、心、胃经，具有清热解毒、抗炎、补虚疗风的功效，主治胀满下疾、温病发热，热毒痈疡和肿瘤等症。其对于头昏头晕、口干作渴、多汗烦闷、肠炎、菌痢、麻疹、肺炎、乙脑、流脑、急性乳腺炎、败血症、阑尾炎、皮肤感染、痈疽疔疮、丹毒、腮腺炎、化脓性扁桃体炎等病症均有一定疗效。
金银花的有效成份为绿原酸和异绿原酸。这是植物代谢过程中产生的次生物质，其含量的高低不仅取决于植物的种类，而且可能在很大程度上受气候、土壤等生态、地理条件以及物候期的影响。
金银花茶有独特的减肥功能，还能抑制与杀灭咽喉部的病原菌，对老人和儿童有抗感染功效。经常服用金银花浸泡或煎剂有利于风火目赤、咽喉肿痛、肥胖症、肝热症和肝热型高血压的治疗与康复。
甜菊叶为使，其含异黄酮成分甜菊素、甜菊素木糖甙、大豆黄酮、大豆黄酮甙及β-谷甾醇、花生酸，又含多量淀粉(新鲜甜菊中含量为19～20%)。甜菊供药用，甜菊提取类黄酮物质与桑叶提取物脱氧野尻霉素结合形成一种新物质—洗胰清糖素（cics），具有降血糖、血脂、抗炎等作用。甜菊有解表退热、生津止渴、止泻的功能，并能改善高血压糖尿病病人的项强、头晕、头痛等症状。有效成分为黄豆甙元、黄甙及甜菊素等。
甜菊主要含碳水化合物，植物蛋白，多种维生素和矿物质，此外还含有黄酮类物质：大豆素，大豆甙，还有大豆素-4，7-二葡萄糖甙，甜菊素，甜菊素-7-木糖甙，甜菊醇，甜菊藤及异黄酮甙等。
与现有技术相比，本发明的有益效果如下：
本发明使用野生苦瓜和川黄连，它们相互作用，各自药性增强，降血糖效果更佳，而野生苦瓜、川黄连、金银花和甜菊叶按上述重量份结合，不仅提升饮料整体的口感，还使得野生苦瓜、川黄连及金银花的整体降血糖效果得到提升。除此之外，还有清热解毒，利水，消炎，保肝明目，清除血液中的毒素，调节体内的酸碱度的作用。本发明无需添加任何化学药剂，无毒副作用，成本低。
在这样的基础上，本发明的野生苦瓜降糖饮料作用功效如下：
1、提高肝细胞的再生能力，恢复正常肝脏机能，促进胆汁分泌，防止和降低脂肪在肝脏堆积。
2、促进新陈代谢，加强肝脏解毒功能，防止酒精对肝脏的损伤。
3、对高血脂形成的冠状动脉硬化，通过改善心肌缺血状态，防治冠心病、心绞痛、心肌梗塞等心血管疾病。
4、对高血脂形成的脑动脉硬化，通过改善脑缺血状态，防治脑梗塞、偏瘫、血管性痴呆等脑血管疾病。
5、强化肝胆细胞自身免疫功能，抵抗病毒入侵。
6、降血糖，具有延缓衰老、调节血脂血糖、促进造血功能等方面的作用，并应用于临床。
以下是本发明方法得到的野生苦瓜降糖饮料的适用人群：
1、成年男子，经常饮酒，抽烟的人士、酒精代谢中毒者；
2、预防肝炎，提高肝脏解毒功能，修复肝损细胞的人群；
3、高血压、高血脂、高血糖及偏头痛等心脑血管病患者；
4、更年期妇女、易上火人群、常用烟酒者；
5、女性滋容养颜，中老年人日常饮食调理等；
6、预防黑斑、青春痘、肝斑的人群；
7、改善微循环促进尿酸结晶溶解，提高肾血流量，促进多排尿酸。
具体实施方式
下面将结合实施例中的技术方案进行清楚、完整地描述，显然，所描述的实施例仅仅是对本发明一部分实例，而不是全部的实例。基于本发明中的实施例，本领域普通技术人员在没有付出创造性劳动前提下所获得的所有其他实施例，都属于本发明保护的范围。
实施例1
本实施例的野生苦瓜降糖饮料，包括如下重量份的原料：野生苦瓜120份、川黄连40份、金银花70份和甜菊叶12份。
本发明涉及的野生苦瓜降糖饮料的制备方法，包括如下步骤：
步骤（1）准备原料
按如下重量份称取原料：野生苦瓜120份、川黄连40份、金银花70份和甜菊叶12份；
步骤（2）制备野生苦瓜降糖饮料
将步骤（1）的原料混合，加水覆盖，大火煮开后，小火煎煮25分钟左右，即得到野生苦瓜降糖饮料。用250毫升、500毫升、1000毫升的食品级塑料瓶装即可。
饮用方法：每日3-5次，每次约200毫升。
禁食：姜、葱、蒜、辣椒、牛羊肉、公鸡肉、鸽子肉及各种鸟肉、白酒、煎炸食品等辛辣上火刺激之物及炭酸饮料；脾、胃虚寒者慎用。
饮用本发明的野生苦瓜饮料的同时辅以如下方法：
每天晚上10点睡觉，早晨5点起床，中午小睡30分钟至1小时，每天早晨跑步40分钟，打太极拳20分钟，晚饭30分钟后快走1小时，随时随地可多做原地跑步，保持平和心态。同时坚持素食，素食有利于降低四高（高血脂、高血糖、高血压、高尿酸），有利于调理人体酸碱度，有利于调理人体代谢，有利于提高人体免疫力，有利于提高抗疲劳能力（素食者抗疲劳的能力高于肉食者三倍以上）。
实施例2
本实施例的野生苦瓜降糖饮料，包括如下重量份的原料：野生苦瓜100份、川黄连35份、金银花63份和甜菊叶10份。
本发明涉及的野生苦瓜降糖饮料的制备方法，包括如下步骤：
步骤（1）准备原料
按如下重量份称取原料：野生苦瓜100份、川黄连35份、金银花63份和甜菊叶10份；
步骤（2）制备野生苦瓜降糖饮料
将步骤（1）的原料混合，加水覆盖，大火煮开后，小火煎煮25分钟左右，即得到野生苦瓜降糖饮料。其余与实施例1相同。
实施例3
本实施例的野生苦瓜降糖饮料，包括如下重量份的原料：野生苦瓜150份、川黄连50份、金银花85份和甜菊叶15份。
本发明涉及的野生苦瓜降糖饮料的制备方法，包括如下步骤：
步骤（1）准备原料
按如下重量份称取原料：野生苦瓜150份、川黄连50份、金银花85份和甜菊叶15份；
步骤（2）制备野生苦瓜降糖饮料
将步骤（1）的原料混合，按常规的低温萃取技术提纯，即得到野生苦瓜降糖饮料。其余与实施例1相同。
实施例4临床案例
1、王某、男、59岁、昆明市人， 空腹血糖15mmoI/L，服用实施例1-3的野生苦瓜饮料一个月后空腹血糖8mmoI/L，服用三个月后空腹血5.8mmoI/L。
2、李某、男、66岁、昆明市人， 空腹血糖18mmoI/L，服用实施例1-3的野生苦瓜饮料一个月后空腹血糖9mmoI/L，服用三个月后空腹血糖5.7mmoI/L。
3、张某、男、76岁、昆明市人，空腹血糖19mmoI/L，服用实施例1-3的野生苦瓜饮料一个月后空腹血糖9.6mmoI/L，服用三个月后空腹血糖5.5mmoI/L。
4、某何、男、57岁、昆明市人， 空腹血糖17mmoI/L，服用实施例1-3的野生苦瓜饮料一个月后空腹血糖8mmoI/L，服用三个月后空腹血糖5.8mmoI/L。
5董某、男、49岁、昆明市人， 空腹血糖17mmoI/L，服用实施例1-3的野生苦瓜饮料一个月后空腹血糖8mmoI/L，服用三个月后空腹血糖水5.6mmoI/L。
6、王某、女、49岁、昆明市人， 空腹血糖15mmoI/L，服用实施例1-3的野生苦瓜饮料一个月后空腹血糖9mmoI/L，服用三个月后空腹血糖5.4mmoI/L。
7、高某、女、59岁、昆明市人， 空腹血糖19mmoI/L，服用实施例1-3的野生苦瓜饮料一个月后空腹血糖8.7mmoI/L，服用三个月后空腹血糖5.8mmoI/L。
8、龙某、女、43岁、昆明市人，空腹血糖15mmoI/L，服用实施例1-3的野生苦瓜饮料一个月后空腹血糖8mmoI/L，服用三个月后空腹血糖水5.9mmoI/L。
9、黄某、女、59岁、昆明市人，空腹血糖16mmoI/L，服用实施例1-3的野生苦瓜饮料一个月后空腹血糖8mmoI/L，服用三个月后空腹血糖水5.3mmoI/L。
10、李某、女、49岁、昆明市人， 空腹血糖18mmoI/L，服用实施例1-3的野生苦瓜饮料一个月后空腹血糖9mmoI/L，服用三个月后空腹血糖5.2mmoI/L。
作为对照，本实施例分别将实施例1中的野生苦瓜替换为普通苦瓜、将川黄连替换为黄连、去除川黄连作为对比例1、2、3，其余与实施例1相同，与实施例1的野生苦瓜降糖饮料效果进行对比，结果如表1所示：
表1 服用不同饮料的效果对比
从表1可以看出的是，野生苦瓜与川黄连的协同作用明显，将两者做替换或者单独作用的疗效均不及两者共同作用。
以上所述仅为本发明的较佳实施例而已，并不用以限制本发明保护范围，凡在本发明的精神和原则之内，所作的任何修改、等同替换、改进等，均应包含在本发明的保护范围之内。
Claims (3)
1.一种野生苦瓜降糖饮料，其特征在于：包括如下重量份的原料：野生苦瓜100-160份、川黄连30-50份、金银花60-88份和甜菊叶10-15份。
2.一种野生苦瓜降糖饮料的制备方法，其特征在于：包括如下步骤：
步骤（1）准备原料
按如下重量份称取原料：野生苦瓜100-160份、川黄连30-50份、金银花60-88份和甜菊叶10-15份；
步骤（2）制备野生苦瓜降糖饮料
将步骤（1）的原料混合，加水覆盖，大火煮开后，小火煎煮25分钟左右或者采用常规低温萃取技术提纯，即得到野生苦瓜降糖饮料。
3.根据权利要求1所述的制备方法，其特征在于：野生苦瓜降糖饮料的用量为：每日3-5次，每次约200毫升。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810942507.7A CN108703282A (zh) | 2018-08-17 | 2018-08-17 | 一种野生苦瓜降糖饮料及其制备方法 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201810942507.7A CN108703282A (zh) | 2018-08-17 | 2018-08-17 | 一种野生苦瓜降糖饮料及其制备方法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN108703282A true CN108703282A (zh) | 2018-10-26 |
Family
ID=63873433
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201810942507.7A Pending CN108703282A (zh) | 2018-08-17 | 2018-08-17 | 一种野生苦瓜降糖饮料及其制备方法 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN108703282A (zh) |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1541701A (zh) * | 2003-11-06 | 2004-11-03 | 温先敏 | 一种治疗糖尿病的药物及制备方法 |
| KR20120014712A (ko) * | 2010-08-10 | 2012-02-20 | 부희옥 | 여주를 주원료로 한 혈당강하용 기능성 음료와 차 및 이의 제조방법 |
| CN103109962A (zh) * | 2013-03-15 | 2013-05-22 | 福建省农业科学院甘蔗研究所 | 新型野苦瓜茶的制备方法 |
| CN103637190A (zh) * | 2013-11-21 | 2014-03-19 | 威海五谷怡健食品有限公司 | 预防和治疗糖尿病的功能食品及其制备方法 |
| CN105994811A (zh) * | 2016-05-23 | 2016-10-12 | 福建省农业科学院亚热带农业研究所 | 一种新型保健茶及其制备方法 |
| CN107594246A (zh) * | 2017-11-02 | 2018-01-19 | 牟凯峰 | 一种辅助降血压、平稳血压饮品 |
-
2018
- 2018-08-17 CN CN201810942507.7A patent/CN108703282A/zh active Pending
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1541701A (zh) * | 2003-11-06 | 2004-11-03 | 温先敏 | 一种治疗糖尿病的药物及制备方法 |
| KR20120014712A (ko) * | 2010-08-10 | 2012-02-20 | 부희옥 | 여주를 주원료로 한 혈당강하용 기능성 음료와 차 및 이의 제조방법 |
| CN103109962A (zh) * | 2013-03-15 | 2013-05-22 | 福建省农业科学院甘蔗研究所 | 新型野苦瓜茶的制备方法 |
| CN103637190A (zh) * | 2013-11-21 | 2014-03-19 | 威海五谷怡健食品有限公司 | 预防和治疗糖尿病的功能食品及其制备方法 |
| CN105994811A (zh) * | 2016-05-23 | 2016-10-12 | 福建省农业科学院亚热带农业研究所 | 一种新型保健茶及其制备方法 |
| CN107594246A (zh) * | 2017-11-02 | 2018-01-19 | 牟凯峰 | 一种辅助降血压、平稳血压饮品 |
Non-Patent Citations (1)
| Title |
|---|
| 唐爱华: ""辨证分型辅以食疗治疗非胰岛素依赖型糖尿病43例"", 《广西中医药》 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN104432084B (zh) | 一种调理粉及其制备方法和用途 | |
| CN102552462B (zh) | 一种泡腾制剂及其制备方法和用途 | |
| KR100941160B1 (ko) | 식혜의 제조방법 | |
| CN104017698B (zh) | 一种冬季调和养生酒及其制备方法 | |
| CN101317615B (zh) | 一种银棘茶饮料及其制备方法 | |
| JP5512590B2 (ja) | 二日酔い解消及び予防用組成物とこれを利用した飲酒前後二日酔い解消用飲み物 | |
| JP4589212B2 (ja) | プロアントシアニジン含有食品及びその製造法 | |
| CN103190659A (zh) | 具有降压降脂和降糖作用的植物饮料及其制备方法和应用 | |
| KR101125677B1 (ko) | 홍삼 및 오미자를 주성분으로 하는 건강기능식품용 진액 조성물, 건강기능식품 및 이의 제조방법 | |
| CN110269224A (zh) | 一种接骨木果冻及其制备方法 | |
| CN103168883A (zh) | 可增强免疫力、抗病原微生物、抗病毒的茶饮料颗粒剂及其制备方法 | |
| CN106360213A (zh) | 一种黄精植物饮料及其制备方法 | |
| KR101483255B1 (ko) | 총백을 이용한 기능성 한방차 및 그 제조방법 | |
| CN106923099A (zh) | 一种金银花植物饮料的制备方法 | |
| KR101452884B1 (ko) | 총백을 이용한 기능성 한방차 및 그 제조방법 | |
| CN108813501A (zh) | 具有清热润肺止咳化痰平喘和调节人体机能的养生蜂蜜膏 | |
| CN105029553A (zh) | 一种果汁蛋钙中药保健饮料及其制备方法 | |
| CN106173714A (zh) | 一种护肝养胃的饮料及其制备方法 | |
| KR20210063657A (ko) | 헛개나무 추출물 및 백년초 분말을 함유한 숙취해소용 천연차 및 그 제조방법 | |
| CN109393110A (zh) | 具有提高免疫力的灵芝茶 | |
| CN108703282A (zh) | 一种野生苦瓜降糖饮料及其制备方法 | |
| KR20120093632A (ko) | 신장염 예방 또는 치료용 약학 조성물 | |
| CN105981853A (zh) | 一种营养功能丰富的温和的暖茶饮料配方 | |
| KR20190006702A (ko) | 모과, 박하, 산수유 함유 기능성음료의 제조방법 및 이로부터 제조된 기능성음료 | |
| CN108013098A (zh) | 一种减肥酸奶蛋糕及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20181026 |